Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition

NCT01827865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Etodolac Extended Release Tablets USP 600mg
DRUG: Etodolac Extended Release Tablets 600mg

Sponsor

IPCA Laboratories Ltd.